Literature DB >> 33471276

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.

Qiuyu Li1, Cheng Cui2, Fei Xu3, Jianping Zhao4, Nan Li5, Haichao Li6, Tianbing Wang7, Hua Zhang5, Na Liu2,8, Yudong Wei2, Xiaoye Niu2, Yan Xu2, Jianping Dong8, Xueting Yao2, Xiaohong Wang1, Yahong Chen1, Haiyan Li2,9, Chunli Song10, Jie Qiao10, Dongyang Liu11, Ning Shen12.   

Abstract

Entities:  

Year:  2021        PMID: 33471276      PMCID: PMC7816738          DOI: 10.1007/s11427-020-1871-4

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


× No keyword cloud information.
Supplementary Method Supporting Information Supporting Information
  2 in total

Review 1.  Ethical review of off-label drugs during the COVID-19 pandemic.

Authors:  Qiu-Yu Li; Ye Lv; Zhuo-Yu An; Ni-Ni Dai; Xue Hong; Yu Zhang; Li-Jun Liang
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

2.  Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo.

Authors:  Haoran Peng; Cuiling Ding; Liangliang Jiang; Wanda Tang; Yan Liu; Lanjuan Zhao; Zhigang Yi; Hao Ren; Chong Li; Yanhua He; Xu Zheng; Hailin Tang; Zhihui Chen; Zhongtian Qi; Ping Zhao
Journal:  Sci China Life Sci       Date:  2021-12-24       Impact factor: 10.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.